Purple Biotech Ratios (2014-2025) | PPBT

Ratios Sep2014 Dec2014 Sep2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Efficiency
Assets Average (Quarter)
82.88M79.22M75.06M71.91M68.25M64.02M60.14M56.58M53.85M50.54M46.64M44.79M42.08M37.96M35.59M36.07M36.32M34.99M36.72M28.32M
Equity Average (Quarter)
77.42M73.61M70.75M67.24M61.71M56.99M53.88M49.60M47.07M44.90M40.73M36.51M32.69M30.23M29.42M31.19M32.80M32.37M32.43M21.24M
Invested Capital (Quarter)
75.09M72.12M69.37M65.11M58.32M55.66M52.11M47.10M47.05M42.74M38.72M34.30M31.09M29.38M29.47M32.91M32.70M32.05M32.81M9.66M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
326.5535.51144.8668.68178.8070.39317.56366.7286.8134.70359.193.00262.71144.084.17-14.7240.17-61.80273.40109.56
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)
0.920.940.940.930.880.900.890.860.890.890.860.770.780.810.840.890.920.930.840.55
Times Interest Earned (Quarter)
326.5535.51144.8668.68178.8070.39317.56366.7286.8134.70359.193.00262.71144.084.17-14.7240.17-61.80273.40109.56
Valuation
Enterprise Value (Quarter)
-55.45M-48.39M-47.69M-46.92M-39.55M-32.90M-33.08M-15.27M-22.73M-18.05M-15.95M-15.34M-10.83M-7.37M-6.29M-7.68M-8.25M-5.59M-8.26M-9.57M
Return Ratios
Return on Capital Employed (Quarter)
28.41%29.08%29.97%26.50%30.68%31.90%38.26%45.64%42.28%48.04%55.93%63.48%64.38%63.30%54.19%34.51%23.88%17.66%16.39%133.51%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%
Return on Equity (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.00%0.00%0.00%0.00%0.01%